1393813-42-7

N-[5-(4-Bromophenyl)-6-chloro-4-pyrimidinyl]-N''-propylsulfamide is a useful synthetic intermediate in the synthesis of Macitentan (M105005); an orally active, potent dual endothelin receptor antagonist used for pulmonary arterial hypertension.